期刊文献+

姜多靶点多途径抗癌机制研究进展 被引量:1

Research progress on anticancer mechanism of ginger via multi-targets and multi-pathways
下载PDF
导出
摘要 综述姜多靶点多途径抗癌机制研究进展。姜含有姜辣素、挥发油等多种植物活性成分,具有抗炎、抗氧化、抑制多种癌细胞增殖、促进癌细胞凋亡、调节免疫、抗病原微生物、抑制癌细胞浸润转移、减缓癌症化疗药毒副作用等多种药理作用。姜及其提取物对癌症的防治具有多成分、多靶点、多途径、多环节、安全无毒的特点,在肺癌、前列腺癌、直肠癌、皮肤癌、肝癌、乳腺癌等的防治中显示出明显效果。 This paper reviews the research progress on anticancer mechanism of ginger via multi-targets and multi-pathways. Ginger contains many kinds of plant active ingredients such as gingerol,volatile oil and so on,and shows many pharmacological effects such as anti-inflammatory,antioxidation,inhibiting the proliferation of various cancer cells,promoting the apoptosis of cancer cells,regulating immune,anti-pathogenic microorganism,inhibiting the invasion and metastasis of cancer cells,and slowing down the toxic and side effects of cancer chemotherapy drugs. Ginger and its extracts show many characteristics in the prevention and treatment of cancer,including multiple components,multiple targets,multiple pathways,multiple links,safe and nontoxicity,and present obvious effects in the prevention and treatment of lung cancer,prostate cancer,rectal cancer,skin cancer,liver cancer,breast cancer and so on.
作者 郭丽丽 王阶
出处 《上海中医药杂志》 2018年第10期109-113,共5页 Shanghai Journal of Traditional Chinese Medicine
基金 国家自然科学基金资助项目(81274129)
关键词 抗癌 安全无毒 多靶点 作用机制 综述 ginger anticancer safe and nontoxicity multi-targets mechanism review
  • 相关文献

参考文献2

二级参考文献57

  • 1徐胜军,胡炳奎,凌志强,赵挺.CD44v6在胃癌中的表达及其临床意义[J].中国普外基础与临床杂志,2006,13(1):42-44. 被引量:8
  • 2Woessner JF Jr.MMPs and TIMPs-an historical perspective[J].Mol Biotechnol,2002;22(1):33-49.
  • 3McCawley LJ,Matrisian LM.Matrix metalloproteinases:th-ey're not just for matrix anymore![J].Curr Opin Cell Biol,2001;13(5):534-540.
  • 4Yu WH,Woessner JF Jr,McNeish JD,et al.CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling[J].Genes Dev,2002;16(3):307-323.
  • 5Suzuki M,Raab G,Moses MA,et al.Matrix metalloproteinase-3 releases active heparin-binding EGF-like growth factor by cleavage at a specific juxtamembrane site[J].J Biol Chem,1997;272(50):31730-31737.
  • 6Rauvala M,Aglund K,Puistola U,et al.Matrix metalloproteinases-2 and -9 in cervical cancer:different roles in tumor progression[J].Int J Gynecol Cancer,2006;16(3):1297-1302.
  • 7Tatti O,Vehvilinen P,Lehti K,et al.MT1-MMP releases latent TGF-beta1 from endothelial cell extracellular matrix via proteolytic processing of LTBP-1[J].Exp Cell Res,2008;314(13):2501-2514.
  • 8Puthawala K,Hadjiangelis N,Jacoby SC,et al.Inhibition of integrin αvβ6,an activator of latent transforming growth factor-beta,prevents radiation-induced lung fibrosis[J].Am J Respir Crit Care Med,2008;177(1):82-90.
  • 9Miyamoto S,Nakamura M,Yano K,et al.Matrix metalloproteinase-7 triggers the matricrine action of insulin-like growth factor-Ⅱ via proteinase activity on insulin-like growth factor binding protein 2 in the extracellular matrix[J].Cancer Sci,2007;98(5):685-691.
  • 10Mysliwy J,Dingley AJ,Sedlacek R,et al.Structural characterization and binding properties of the hemopexin-like domain of the matrixmetalloproteinase-19[J].Protein Expr Purif,2006;46(2):406-413.

共引文献45

同被引文献16

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部